182 related articles for article (PubMed ID: 25704023)
21. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.
Prasad S; Yadav VR; Kannappan R; Aggarwal BB
J Biol Chem; 2011 Feb; 286(7):5546-57. PubMed ID: 21156789
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells.
Kwak JH; Park JY; Lee D; Kwak JY; Park EH; Kim KH; Park HJ; Kim HY; Jang HJ; Ham J; Hwang GS; Yamabe N; Kang KS
Bioorg Med Chem Lett; 2014 Dec; 24(23):5409-12. PubMed ID: 25453798
[TBL] [Abstract][Full Text] [Related]
23. Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
Sun T; Zhu T; Liang X; Yang S; Zhao R
Med Sci Monit; 2018 Apr; 24():2550-2561. PubMed ID: 29695684
[TBL] [Abstract][Full Text] [Related]
24. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
Wang W; Wang H; Rayburn ER; Zhao Y; Hill DL; Zhang R
Br J Cancer; 2008 Feb; 98(4):792-802. PubMed ID: 18253123
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside metabolite 20(S)‑protopanaxadiol promotes neural stem cell transition from a state of proliferation to differentiation by inducing autophagy and cell cycle arrest.
Chen S; He J; Qin X; Luo T; Pandey A; Li J; Liu S; Luo J; Wang Q; Luo Z
Mol Med Rep; 2020 Jul; 22(1):353-361. PubMed ID: 32319663
[TBL] [Abstract][Full Text] [Related]
26. 20(S)-Protopanaxadiol from
Song C; Shen T; Kim HG; Hu W; Cho JY
Am J Chin Med; 2023; 51(1):205-221. PubMed ID: 36408728
[TBL] [Abstract][Full Text] [Related]
27. 20(s)-Protopanaxadiol (PPD) increases the radiotherapy sensitivity of laryngeal carcinoma.
Teng B; Zhao L; Gao J; He P; Li H; Chen J; Feng Q; Yi C
Food Funct; 2017 Dec; 8(12):4469-4477. PubMed ID: 29090703
[TBL] [Abstract][Full Text] [Related]
28. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
29. Ginseng metabolite protopanaxadiol interferes with lipid metabolism and induces endoplasmic reticulum stress and p53 activation to promote cancer cell death.
Jin HR; Du CH; Wang CZ; Yuan CS; Du W
Phytother Res; 2019 Mar; 33(3):610-617. PubMed ID: 30537241
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
[TBL] [Abstract][Full Text] [Related]
31. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
Qiao X; Wang X; Shang Y; Li Y; Chen SZ
Cancer Commun (Lond); 2018 Jul; 38(1):43. PubMed ID: 29970185
[TBL] [Abstract][Full Text] [Related]
32. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells.
Lee JI; Ha YW; Choi TW; Kim HJ; Kim SM; Jang HJ; Choi JH; Choi MH; Chung BC; Sethi G; Kim SH; Ahn KS; Choi SH; Shim BS; Ahn KS
Planta Med; 2011 Jan; 77(2):133-40. PubMed ID: 20669086
[TBL] [Abstract][Full Text] [Related]
33. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
34. Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors.
Phillips DC; Buchanan FG; Cheng D; Solomon LR; Xiao Y; Xue J; Tahir SK; Smith ML; Zhang H; Widomski D; Abraham VC; Xu N; Liu Z; Zhou L; DiGiammarino E; Lu X; Rudra-Ganguly N; Trela B; Morgan-Lappe SE
Cancer Res; 2021 Jun; 81(12):3402-3414. PubMed ID: 33687950
[TBL] [Abstract][Full Text] [Related]
35. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
[TBL] [Abstract][Full Text] [Related]
37. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
38. A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
Toriyama S; Horinaka M; Yasuda S; Taniguchi T; Aono Y; Takamura T; Morioka Y; Miki T; Ukimura O; Sakai T
Mol Cancer Ther; 2016 Sep; 15(9):2066-75. PubMed ID: 27406983
[TBL] [Abstract][Full Text] [Related]
39. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.
Huang M; Zhu H; Yi C; Yan J; Wei L; Yang X; Chen S; Huang Y
Cancer Chemother Pharmacol; 2018 Nov; 82(5):829-838. PubMed ID: 30167846
[TBL] [Abstract][Full Text] [Related]
40. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]